These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32757783)

  • 1. Uremic solutes of indoxyl sulfate and
    Kim SJ; Zhang X; Cho SB; Kim CH; Park HC; Moon SJ
    Hum Exp Toxicol; 2021 Jan; 40(1):113-123. PubMed ID: 32757783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
    Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
    Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Tubular Secretion of Organic Solutes in Advanced Chronic Kidney Disease.
    Mair RD; Lee S; Plummer NS; Sirich TL; Meyer TW
    J Am Soc Nephrol; 2021 Nov; 32(11):2877-2884. PubMed ID: 34408065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
    Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
    Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
    Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
    Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
    Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbe-derived uremic solutes enhance thrombosis potential in the host.
    Nemet I; Funabashi M; Li XS; Dwidar M; Sangwan N; Skye SM; Romano KA; Cajka T; Needham BD; Mazmanian SK; Hajjar AM; Rey FE; Fiehn O; Tang WHW; Fischbach MA; Hazen SL
    mBio; 2023 Dec; 14(6):e0133123. PubMed ID: 37947418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-bound uremic toxins induce tissue remodeling by targeting the EGF receptor.
    Sun CY; Young GH; Hsieh YT; Chen YH; Wu MS; Wu VC; Lee JH; Lee CC
    J Am Soc Nephrol; 2015 Feb; 26(2):281-90. PubMed ID: 25012179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
    Ito S; Yoshida M
    Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and sustainable HPLC method for the determination of uremic toxins in human plasma samples.
    Silva LAP; Campagnolo S; Fernandes SR; Marques SS; Barreiros L; Sampaio-Maia B; Segundo MA
    Anal Bioanal Chem; 2023 Feb; 415(4):683-694. PubMed ID: 36464734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A uremic solute, P-cresol, inhibits the proliferation of endothelial progenitor cells via the p38 pathway.
    Ying Y; Yang K; Liu Y; Chen QJ; Shen WF; Lu L; Zhang RY
    Circ J; 2011; 75(9):2252-9. PubMed ID: 21747198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane.
    Tust M; Müller JP; Fischer D; Gründemann D
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenyl sulfate, indoxyl sulfate and p-cresyl sulfate decrease glutathione level to render cells vulnerable to oxidative stress in renal tubular cells.
    Edamatsu T; Fujieda A; Itoh Y
    PLoS One; 2018; 13(2):e0193342. PubMed ID: 29474405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease.
    Summers SC; Quimby JM; Isaiah A; Suchodolski JS; Lunghofer PJ; Gustafson DL
    J Vet Intern Med; 2019 Mar; 33(2):662-669. PubMed ID: 30561098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.
    Poesen R; Viaene L; Verbeke K; Claes K; Bammens B; Sprangers B; Naesens M; Vanrenterghem Y; Kuypers D; Evenepoel P; Meijers B
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1508-14. PubMed ID: 23813557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection].
    Watanabe H
    Yakugaku Zasshi; 2013; 133(8):889-95. PubMed ID: 23903229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.